CKD-EPI 2021 - Estimated Glomerular Filtration Rate
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۰.۱ — حداکثر ۲۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- G1≥ 90
- G260–89
- G3a45–59
- G3b30–44
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Renal Failure, Electrolytes & Dosing — نارسایی کلیه، الکترولیتها و تنظیم دوز
Clinical Rationale:
Estimate GFR with CKD-EPI 2021 and Cockcroft-Gault for pharmacokinetic dosing. Stage AKI with AKIN, differentiate prerenal azotemia with FENa and FEUrea, and correct calcium and free water deficits.
Recommended Clinical Next Steps:
Creatinine Clearance (Cockcroft-Gault Equation)
کلیرانس کراتینین (کاکرافت-گالت)
Why next: Pharmacokinetic drug dosing clearanceAKIN Classification for Acute Kidney Injury (AKI)
طبقهبندی AKIN (آسیب حاد کلیوی)
Why next: Acute kidney injury stagingFractional Excretion of Sodium (FENa)
دفع جزئی سدیم (FENa)
Why next: Prerenal azotemia vs acute tubular necrosis
The CKD-EPI 2021 - Estimated Glomerular Filtration Rate calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include sex. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
CKD-EPI 2021 equation to estimate glomerular filtration rate (eGFR) based on serum creatinine, age, and sex. This 2021 version removed the race component from the original equation.
Clinical Indication
The CKD-EPI 2021 - Estimated Glomerular Filtration Rate is indicated for bedside clinical practice to support CKD-EPI 2021 equation to estimate glomerular filtration rate (eGFR) based on serum creatinine, age, and sex. This 2021 version removed the race component from the original equation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.
Limitations & Contraindications
eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.
Clinical Pearls & Action Plan
Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.
eGFR = 142 × min(SCr/κ,1)^α × max(SCr/κ,1)^(-1.200) × 0.9938^Age × 1.012 [if female]
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Patient's sex |
| age | integer | Yes | Patient's age in years(years) |
| serum_creatinine | float | Yes | Standardized serum creatinine(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 90 | G1 | Normal or high kidney function |
| 60–89 | G2 | Mild decrease in GFR |
| 45–59 | G3a | Mild to moderate decrease in GFR |
| 30–44 | G3b | Moderate to severe decrease in GFR |
| 15–29 | G4 | Severe decrease in GFR |
| 0–14 | G5 | Kidney failure |
Evidence-Based References (EBM)
- Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749.
- National Kidney Foundation. CKD-EPI Creatinine Equation (2021). https://www.kidney.org/ckd-epi-creatinine-equation-2021-0